Halocin C8 (HalC8) is a stable microhalocin exhibiting strong antimicrobial activity against a wide range of haloarchaea. HalI, a 207-amino-acid peptide derived from the N terminus of the HalC8 preproprotein, is the immunity protein of HalC8. In this study, the molecular mechanism of the immunity function of HalI was investigated. Both pull-down and surface plasmon resonance assays revealed that HalI directly interacted with HalC8, and a mixture of purified HalI and HalC8 readily formed a heterocomplex, which was verified by gel filtration. Interestingly, HalC8 tended to form a self-associated complex, and one immunity protein likely sequestered multiple halocins. Significantly, the helix-loop-helix (HLH) motif containing a 4-amino-acid repeat (RELA) at the N terminus of HalI played a key role in its immunity activity. Disruption of the HLH motif or mutagenesis of the key residues of the RELA repeat resulted in loss of both the immunity function and the ability of HalI to bind to HalC8. These results demonstrated that HalI sequestered the activity of HalC8 through specific and direct binding.
Halocins are proteinaceous antibiotics that are ribosomally synthesized by extremely halophilic archaea and excreted into the environment to kill or inhibit other haloarchaeal cells (15) . Halocins were first discovered in 1982 (23) and later were found to be produced by most rod-shaped haloarchaea (12, 32) . So far, several halocins have been purified and characterized (7, 11, 15, 17, 31) , and three halocin genes coding for H4 (halH4), S8 (halS8), and C8 (proC8) have been cloned (2, 19, 29) . Although the amino acid sequences of these halocins are quite diverse, the halocins share many features. For example, halocins are usually produced upon transition from the exponential to stationary phase and are processed from larger precursor proteins (2, 19, 29) . In addition, halocins appear to be exported by a twin-arginine translocation (Tat) pathway (24, 29) , as their precursors usually contain a Tat signal at their N termini (2, 19, 29) . Accordingly, halocin has been considered a good model for examining gene expression regulation and protein processing and transportation in haloarchaea.
HalC8 is an extremely stable microhalocin with a wide inhibition spectrum (7) . The HalC8 gene encodes a 283-aminoacid preproprotein (ProC8), which is processed into two functional peptides, the C-terminal peptide antibiotic HalC8 (76 amino acids) and the N-terminal immunity protein HalI (29) . As far as we know, HalI is the only halocin immunity protein that has been characterized. It is likely oriented toward the outside of the cellular membrane and hence inhibits HalC8 by sequestration (29) . However, the molecular details of the interaction between HalI and HalC8 have not been elucidated yet. In this study, we demonstrated that HalI blocked HalC8 activity by direct interaction with HalC8. The motif and residues of HalI required for this functional interaction were also determined.
MATERIALS AND METHODS
Strains and growth conditions. Escherichia coli DH5␣ (Clontech) and E. coli BL21(DE3) (Novagen) were grown in LB medium (25) at 37°C. The halophilic archaeon Natrinema sp. strain AS7092 (formerly Halobacterium sp. strain AS7092, which was renamed becasue its 16S rRNA gene [accession number AY899297] exhibits 99.1% identity with that of the newly described organism Natrinema altunense [accession number AY208972]) (7, 34) , Halorubrum saccharovorum ATCC 29252, and Haloferax volcanii DS70 (33) were cultivated at 37°C in AS-169 or AS-168 medium as described previously (7) . When needed, kanamycin, ampicillin, or mevinolin was added to a final concentration of 50, 100, or 3 g/ml for selection.
Mutagenesis, plasmid construction, and protein expression. The plasmids used in this study are listed in Table 1, and the primers used are listed in Tables  S1 and S2 in the supplemental material. For expression of the HalI protein and mutant proteins with an N-terminal polyhistidine tag (His 6 ), the pET28a system (Table 1) was used. Briefly, the coding sequence of HalI was amplified with primers HalIF and HisHalI28R (see Table S1 in the supplemental material) and cloned into the expression vector pET28a, resulting in pET-HalI (Table 1) , which was used to express His 6 -HalI in E. coli. Similarly, primers HalI41F, HalI61F, and HalI66F combined with primer HisHalI28R (see Table S1 in the supplemental material) were used for construction of the expression plasmids pET-HalI⌬N41, pET-HalI⌬N61, and pETHalI⌬N66, respectively, which were used to express N-terminally truncated HalI mutants (Table 1 ). In the same way, primers HalI180R, HalI170R, HalI150R, and HalI120R combined with primer HalIF (see Table S1 in the supplemental material) were used to construct the expression plasmids pET-HalI⌬C180, pETHalI⌬C170, pET-HalI⌬C150, and pET-HalI⌬C120, respectively, which were used to express C-terminally truncated HalI mutants (Table 1) . To search for the functional motifs and the key amino acids in HalI, site-directed mutagenesis of halI was performed as previously described (6) . Briefly, pET-HalI containing the halI sequence was used as the template. Primers shown in Table S2 in the supplemental material were designed to introduce desired mutations into pETHalI with KOD-plus DNA polymerase (Toyobo, Japan). The parental template DNA and the newly synthesized mutagenesis-primer-containing DNA were treated with DpnI and then introduced into E. coli. In this way, the pET-HalIderived plasmids pET-H1m, pET-H2m, pET-HLHm, pET-H3m, and pET-H4m with specific mutations in the corresponding helix motifs of HalI (Table 1) were  obtained. Fifteen other plasmids expressing HalI mutants, designated A61D,  R62A, E63A, L64A, A65P, K66A, T67A, P68A, A69V, F70A, R71A, E72A,  L73A, A74V, and Q75A (see Table S2 in the supplemental material), with a point mutation for each amino acid (from residue 61 to residue 75) in the helix-loop-helix (HLH) motif, were also constructed. All these plasmids were constructed in E. coli DH5␣, verified by DNA sequencing, and then transformed into E. coli BL21(DE3) (Novagen) for protein expression. Overexpressed His 6 -tagged HalI and HalI mutants were purified on Ni-nitrilotriacetic acid (NTA) columns used according to the manufacturer's instructions (Novagen). The concentrations of the purified proteins (purity, Ͼ95%) were determined with a bicinchoninic acid protein assay kit (Pierce).
To express HalI and its variants in haloarchaea, the halI gene and corresponding mutant genes were amplified from plasmids pET-HalI, pET-H1m, pETH2m, and pET-HLHm (Table 1) with primers PrF and HalIR (see Table S1 in the supplemental material) and cloned into the shuttle vector pWL102 (5), resulting in plasmids pWL-HalI, pWL-HalIH1m, pWL-HalIH2m, and pWLHalIHLHm (Table 1) , respectively. These plasmids were transformed into H. volcanii DS70 as described by Cline et al. (3) . All the PCR-amplified DNA sequences were confirmed by DNA sequencing.
Pull-down assay. To detect the direct interaction between HalC8 and HalI, plasmid pET26-HalC8 (Table 1) containing the halC8 sequence (amplified with primers HisC8F and HisC8R [see Table S1 in the supplemental material]) was used to express the HalC8 protein with a C-terminal polyhistidine tag (HalC8-His 6 ) in E. coli BL21(DE3), while the HalI protein with an N-terminal glutathione S-transferase (GST) tag (GST-HalI) was expressed by pGEX-HalI (Table  1) , which was constructed by cloning the halI sequence (amplified with primers HalIF and GST-HalIR [see Table S1 in the supplemental material]) into pGEX-4T-1 (Table 1) . For the pull-down assay, purified HalC8-His 6 (as the bait) was mixed with Ni-NTA beads (Novagen) and then washed three times with washing buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 20 mM imidazole; pH 8.0). After this, cell lysates of BL21(DE3)/pGEX4T-1 and BL21(DE3)/pGEX-HalI cultures containing overexpressed GST and GST-HalI, respectively, were incubated with HalC8-His 6 -immobilized Ni-NTA beads at room temperature for 1 to 2 h. After three washes with the washing buffer, the bound proteins on the Ni-NTA beads were eluted by using elution buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole; pH 8.0), separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), and visualized by immunoblotting with antiserum against GST-HalI as described previously (29) .
SPR assay. The surface plasmon resonance (SPR) assay was carried out by using a BIAcore 3000 instrument (BIAcore AB, Uppsala, Sweden) (16) . For immobilization of HalI⌬N41 on a CM5 chip (BIAcore AB, Uppsala, Sweden), the chip surface was first activated with 35 l of a 1:1 mixture of N-hydroxysuccinimide (0.1 M) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (0.4 M), and then HalI⌬N41 (5 to 20 l; 50 g/ml in 10 mM sodium acetate buffer [pH 4.0]) was injected and immobilized to obtain 900 resonance units. After this, the remaining active groups were blocked with 35 l of ethanolamine (1 M, pH 8.5). Throughout this immobilization procedure, the flow rate was kept at 5 l/min. For detection of the interaction between HalI⌬N41 and HalC8, natural HalC8 protein purified from the culture medium of the halophilic archaeon Natrinema sp. strain AS7092 (7) was diluted in HBS buffer (10 mM HEPES [pH 7.5], 150 mM NaCl, 3 mM EDTA, 0.005% [vol/vol] surfactant P20) to obtain different concentrations (5 to 100 M) and injected with the K-inject command. At the end of each cycle, 50 mM NaOH was used as regeneration buffer to remove the bound HalC8. A blank flow cell was used as a control for each concentration of HalC8. HBS buffer was used as the running buffer throughout the binding analysis at a flow rate of 30 l/min.
Gel filtration chromatography and electrophoresis. For examination of the HalI-HalC8 interaction complex, gel filtration chromatography was performed. Samples (100 l) of purified HalI⌬N41 protein from E. coli, purified natural HalC8 from Natrinema sp. strain AS7092, and a mixture of both these proteins (after incubation at 37°C for 2 to 4 h) were subjected to analytical gel filtration chromatography on a Superdex 200 10/300 GL column (GE Healthcare), which was equilibrated and eluted with elution buffer (50 mM Tris-HCl, 150 mM NaCl; pH 8.0). The columns used in this study were calibrated by using a set of gel filtration markers (Sigma), including ␤-amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), bovine carbonic anhydrase (29 kDa), and horse cytochrome c (12.4 kDa). In all gel filtration experiments, the flow rate was 0.5 ml/min, and samples were collected by using 1 ml/fraction. The eluted samples of HalI⌬N41 or the HalI⌬N41-HalC8 mixture were analyzed by Western blot analysis with anti-GST-HalI polyclonal antibodies. For investigation of the possible oligomerization of HalI, purified HalI⌬N41 was divided into two aliquots. One aliquot was mixed with an equal volume of 2ϫ denaturing buffer (100 mM Tris-HCl, 400 mM dithiothreitol, 4% SDS, 20% glycerol, 0.2% bromophenol blue; pH 6.8) and boiled for 10 min, while the other aliquot was mixed with native sample buffer (100 mM Tris-HCl, 20% glycerol, 0.2% bromophenol blue) and kept on ice before loading. Both aliquots were subjected to 5 to 15% gradient native PAGE (14) with Tris-glycine buffer (pH 8.8).
To determine the oligomerization of HalC8, the active fractions of natural HalC8 eluted from a Superdex 75 10/300 GL column (GE Healthcare) were concentrated and split into two aliquots. One aliquot was denatured as described above for HalI⌬N41, while the other aliquot was not treated. Both aliquots were subjected to Tricine-SDS-PAGE as previously described (26) .
Evaluation of the immunity function of HalI and HalI mutants. The microtiter plate assay (7) with H. saccharovorum cells as the indicator was used to evaluate the immunity function of HalI and HalI mutants against HalC8. Briefly, natural HalC8 (10 nM) was mixed with the same volume of purified His 6 -HalI or His 6 -HalI mutants, which were diluted in 50 mM Tris-HCl (pH 8.0) using the double-dilution method and the same starting concentration (1 M). The mixtures were loaded into the wells in an indicator plate and incubated at 37°C for 2 to 3 days. The highest dilution of HalI or a HalI mutant that exhibited inhibition activity against HalC8 was considered the relative activity of the immunity function.
Evaluation of the binding affinity of HalI mutants. An enzyme-linked immunosorbent assay (ELISA) was used to evaluate the binding affinity of HalI mutants, as described by Quadri et al. (20) . Briefly, a 96-well ELISA plate was first coated with purified natural HalC8 (10 g/well, diluted in 0.05 M NaHCO 3 [pH 9.6]) and blocked with 0.5% bovine serum albumin (diluted in phosphate buffer [pH 7.4]). Subsequently, 200 l of a 1.5 M solution of His 6 -HalI or a His 6 -HalI mutant was added to each well and incubated for 2 h at room temperature. Then anti-GST-HalI antibody and horseradish peroxidase-conjugated anti-immunoglobulin G antibody were added sequentially, with incubation for 2 h for each step. The plate was always washed three times with phosphate buffer (pH 7.4) before reagents were changed. After this, a substrate solution containing tetramethyl benzidine (Tiangen, People's Republic of China) was added and incubated at 37°C for 10 to 15 min; then the reaction was terminated by using 2 M H 2 SO 4 , and the absorbance at 450 nm was determined with a plate reader. The binding activities of HalI and the mutants were evaluated by determining the absorption at 450 nm after the absorption of the bovine serum albumin negative control was subtracted; the binding activity of HalI was arbitrarily defined as 100%.
Heterologous expression of HalI and HalI mutants in haloarchaea. The expression plasmids pWL-HalI, pWL-HalIH1m, pWL-HalIH2m, and pWLHalIHLHm (Table 1) were transformed into H. volcanii DS70. For detection of the expression of HalI and HalI mutants, the H. volcanii DS70 transformants were collected after they entered stationary phase and subjected to Western blot analysis as described previously (29) . For the HalC8 sensitivity assay, the H. volcanii DS70 transformants were streaked onto an assay plate containing 3 g/ml mevinolin and 50 nM natural HalC8. A mevinolin-containing plate without HalC8 was used as a negative control. The plates were incubated at 37°C for up to 1 week.
RESULTS
HalI interacts with HalC8 through direct binding. Our previous investigation revealed that HalC8 is likely intercepted, but not destroyed, when it is inhibited by the immunity protein HalI (29) . However, the molecular details of the interaction between HalI and HalC8 remain unclear. To further investigate this interaction, both HalC8-His 6 and GST-HalI were expressed in E. coli and used in a pull-down assay. Purified HalC8-His 6 protein was immobilized on Ni-NTA beads and then incubated with cell lysates containing similar amounts of GST-HalI or GST (as a negative control). The bound proteins were identified by a Western blot assay with the anti-GST-HalI antibody. As shown in Fig. 1 , GST-HalI, but not GST, was specifically pulled down by the HalC8-His 6 protein. This result indicated that HalI likely interacted with HalC8 through direct and specific binding.
To confirm this, the interaction between purified natural HalC8 and the HalI peptide without its signal sequence (designated HalI⌬N41), which had complete HalI activity, was analyzed by the SPR assay. The HalI⌬N41 peptide was immobilized on the CM5 sensor chip, and different concentrations of purified natural HalC8 (isolated from Natrinema sp. strain AS7092) were injected. After subtraction of the blank cell signals, the signals specific for binding of HalC8 on HalI⌬N41 were clearly observed (Fig. 2) . The SPR data were further analyzed by using the BIAEVAL software, and the equilibrium dissociation constant was calculated to be about 1.2 M, indicating that the interaction between HalI and HalC8 in vitro was a moderate-affinity interaction.
HalI and HalC8 form a large heterocomplex in vitro. Although HalC8 might directly bind to HalI, it is likely that an unexpected large heterocomplex between these molecules was formed, as the resulting interaction complex was not able to enter a native gel when an attempt to collect the complex was made (29) . To obtain more information about this interaction, gel filtration chromatography was performed to identify the interaction complex. To do this, purified HalI⌬N41 was incubated with excess natural HalC8 at 37°C for 2 to 4 h and then subjected to gel filtration chromatography. Significantly, the HalI⌬N41-HalC8 heterocomplex eluted as a single peak, which formed only after HalC8 and HalI⌬N41 were mixed. However, its molecular mass was more than 200 kDa as estimated by gel filtration chromatography (Fig. 3A) , which is much greater than the predicted molecular mass (31 kDa) of a heterocomplex consisting of a 1:1 mixture of single molecules of HalI⌬N41 (23.5 kDa) and natural HalC8 (7.4 kDa). The identities of the HalI⌬N41 peptide and the constituents of the HalI⌬N41-HalC8 complex in the eluted collections were confirmed by Western blot analysis with the anti-GST-HalI antibody ( Fig. 3B and C) . To understand why the molecular mass of the complex was much greater than predicted, we analyzed purified HalI⌬N41 and natural HalC8. HalI⌬N41 eluted as a single peak with an estimated molecular mass of about 50 kDa, which is greater than the predicted molecular mass, 23.5 kDa (Fig. 3A) . It is likely that this functional region of HalI has a tendency to form a dimer. However, analysis by native gradient PAGE indicated that HalI did not form oligomers, as the molecular weight of native HalI⌬N41 was the same as that of denatured HalI⌬N41 (Fig. 3D) . Hence, the higher apparent molecular weight of HalI deduced from gel filtration chromatography was likely due to its specific molecular shape (e.g., chainlike structure) and/or amino acid features (e.g., strong hydration caused by the acidic residues in HalI). Interestingly, while the molecular mass of HalC8 is 7.4 kDa (29), the samples of HalC8 eluted in gel filtration chromatography were a main peak corresponding to a molecular mass of about 23 kDa and a minor peak corresponding to a molecular mass of about 45 kDa (Fig. 3A and  4A ), which were likely a trimer and a hexamer of HalC8, respectively. To confirm this, the active fractions (Fig. 4B) were concentrated and split into two aliquots. One aliquot was denatured, and the other aliquot was not denatured; both aliquots were subjected to Tricine-SDS-PAGE. The molecular mass of the denatured HalC8 was indeed found to be about 7.4 kDa, while the molecular mass of the nondenatured form of HalC8 appeared to be 23 kDa (Fig. 4A, inset) , as revealed by gel filtration chromatography. However, the 45-kDa band was not detectable, likely due to a low protein concentration for the minor peak. These results demonstrated that HalC8 had a strong tendency to form self-associated oligomers. Therefore, the large HalI⌬N41-HalC8 heterocomplex may be due to oligomerization of HalC8, which might associate with more HalI⌬N41 molecules.
The HLH motif of HalI is essential for the immunity function. To search the putative active domain of HalI, the amino acid sequence of HalI was analyzed by using the PredictProtein program (http://www.predictprotein.org/). It was found that there were four helices (Fig. 5A ) in the immunity function region of HalI (amino acids 41 to 207) downstream of the putative signal sequence (amino acids 1 to 40). The first two helices constituted a typical HLH motif at the N terminus of HalI, and there was a 4-amino-acid repeat (RELA) in these two helices (Fig. 5B) . The other two helices were located in the middle (amino acids 98 to 112) and at the C terminus (amino acids 180 to 188) ( Fig. 5A and B) .
To investigate the function of these helices in the immunity activity of HalI, we constructed a series of truncated HalI mutants by deletion from the N-terminal and C-terminal regions. As shown in Fig. 5A , the HalI⌬N41 truncated mutant without the signal sequence (amino acids 1 to 40) and HalI⌬N61 without amino acids 1 to 60 showed complete immunity activity in vitro. However, when amino acids 61 to 65 were also deleted, the resultant mutant, HalI⌬N66, exhibited no immunity activity. Since the sequence from amino acid 62 to amino acid 65 is one unit of the RELA repeat in the HLH motif (Fig. 5B) , we presumed that the repeat or the HLH motif was probably important for HalI activity. In contrast to the N terminus, the C terminus likely has no key section for HalI activity (Fig. 5A ). HalI⌬C180 without amino acids 181 to 207, including helix 4 (residues 180 to 188), showed complete immunity activity. From HalI⌬C170 to HalI⌬C120, the immunity activity was gradually reduced along with the C-terminal deletion. The C terminus of HalI is rich in acidic residues, which are thought to be important for proteins to adapt to high-salt conditions (4, 8, 9, 13) . Thus, the C terminus of HalI probably makes the structure more stable at high salt concentrations.
To confirm this hypothesis, we constructed several mutants with mutations in these helices (designated H1m, H2m, H3m, H4m, and HLHm) by using site-directed mutagenesis (see Table S2 in the supplemental material). Significantly, once the HLH motif at the N terminus of HalI was disrupted (H1m, H2m, or HLHm), there was little or no immunity activity of the mutant. In contrast, the activities of helix 3 and helix 4 mutants (H3m and H4m) were the same as the activity of wild-type HalI (Fig. 5C ). These results supported our hypothesis that the HLH motif is essential for the HalI immunity function.
To determine which amino acid in the HLH motif plays a key role in the immunity function of HalI, we constructed HalI mutants with single-amino-acid mutations at amino acids 61 to 75 (see Table S2 in the supplemental material). The activities of the L64A and L73A mutants were much lower than that of wild-type HalI (Fig. 5C) , indicating that the L64 and L73 res- idues in the RELA repeat (Fig. 5B ) play a very important role in the immunity activity of HalI. Direct binding of HalI to HalC8 is required for the immunity function. To establish the relationship between the immunity function and the binding ability of HalI, a modified ELISA was performed to quantify the binding affinity of HalI mutants with HalC8. After HalC8 was coated in the ELISA plate, HalI and mutants H1m, H2m, H3m, H4m, HLHm, A61D, R62A, E63A, L64A, A65P, K66A, T67A, P68A, A69V, F70A, R71A, E72A, L73A, A74V, and Q75A (see Table S2 in the supplemental material) were incubated with HalC8. The absorption for each ELISA reaction representing binding activity of HalI or a HalI mutant was determined. The binding activity of HalI was arbitrarily defined as 100%, and the activities of the mutants were expressed as percentages of the HalI activity, as shown in Fig. 5C . The binding activities of mutants H1m, H2m, L64A, and L73A were much lower than that of wild-type HalI, consistent with their immunity activities. Most significantly, the binding activity of mutant HLHm was hardly detectable, which was verified by SPR and gel filtration chromatography (data not shown), and the immunity function was completely lost (Fig. 5C ). These results demonstrated that the binding ability was directly correlated with the immunity function of HalI and further confirmed that HalI sequestered HalC8 activity by direct binding.
The HLH motif is necessary for the immunity function of HalI in vivo. To determine whether the HLH motif is important for the biological function of HalI in vivo, the expression plasmids pWL-HalI, pWL-HalIH1m, pWL-HalIH2m, and pWL-HalIHLHm (Table 1) were transformed into a HalC8-sensitive haloarchaeon, H. volcanii DS70. Western blot analysis revealed that both HalI and HalI mutants were successfully expressed in the transformants, and the expression levels were almost the same (Fig. 6A) . After culturing for up to 1 week in plates, all these strains grew very well on the control plate with 3 g/ml mevinolin but without HalC8 (Fig. 6B, left panel) , and DS70/pWL-HalI also grew well on the assay plate containing 3 g/ml mevinolin and 50 nM HalC8 (Fig. 6B, right panel) . In contrast, mutants DS70/pWL-HalIH1m and DS70/pWLHalIHLHm were not able to grow, and DS70/pWL-HalIH2m exhibited only poor growth on the assay plate (Fig. 6B, right  panel) . These results showed that the HLH motif was indeed essential for the immunity function of HalI, which could provide the HalC8-sensitive haloarchaeal strain with HalC8 resistance.
DISCUSSION
Halocin production is a practically universal feature of most haloarchaeal rods (32) , like bacteriocins produced in the domain Bacteria (22) . However, the halocin immunity protein has been identified only for HalC8 (29) . This immunity protein, designated HalI, is localized in cytoplasmic membrane of haloarchaeal strain AS7092, the producer of HalC8 (29) . The immunity function of HalI against HalC8 is specific and efficient, but the underlying mechanism of this immunity function is not clear. In the present study, we found that HalI directly binds to HalC8 and forms a stable heterocomplex, inhibiting HalC8 from approaching and killing the producer cells. We also demonstrated that the HLH motif at the N terminus of HalI plays a key role in both the binding ability and the immunity function.
This immunity mechanism for HalI against HalC8 involving specific binding resembles that of the bacteriocin immunity protein NisI, which intercepts nisin at the surface of the cytoplasmic membrane (28) . The equilibrium dissociation constant (1.2 M) for the binding interaction between HalI and HalC8 evaluated by the SPR assay was similar to that for the NisInisin interaction (range, 0.6 to 2 M) (30) . The moderately strong binding may be helpful for releasing the captured peptide antibiotic into the environment again by some unknown mechanism. Interestingly, similar to genes observed in the nisin gene cluster, genes encoding a system homologous to an ABC transporter were found in the halC8 gene cluster (10) . The transporter system may also play an additional role in the halocin tolerance of the producer, like NisFEG, which seems to work by expelling cell-attached nisin molecules into the environment (28) . It is reasonable to suggest that the HalC8 captured by HalI could be released into the environment with the help of the ABC transporter. However, the molecular details of the HalC8 released from HalI or cellular membrane remain to be elucidated.
Interestingly, the direct interaction between HalI and HalC8 likely involved the HLH motif of HalI. The HLH motifs common to several known transcription factors usually control the affinity of proteins for homo-or heterodimerization (1) and play an important role in some protein-protein interactions (18) . Although HalI⌬N41 had a higher apparent molecular mass (ϳ50 kDa) as determined by gel filtration chromatography (Fig. 3A) , this molecular mass was likely not due to HLH- 
